Relation of lower hematocrit to progression from asymptomatic left ventricular dysfunction to symptomatic heart

Sandeep R Das1, Daniel L Dries, Mark H Drazner

  • 1Donald W. Reynolds Cardiovascular Clinical Research Center, Dallas, Texas, USA. sandeep.das@utsouthwestern.edu

Insights

Low hematocrit levels (< or = 40%) are linked to a higher risk of developing heart failure (HF) symptoms and hospitalization. This finding highlights hematocrit as a potential indicator for HF progression in patients with left ventricular systolic dysfunction.

Area of Science:

  • Cardiology
  • Hematology

Background:

  • Left ventricular (LV) systolic dysfunction is a precursor to symptomatic heart failure (HF).
  • The role of hematocrit in the progression of asymptomatic LV dysfunction to symptomatic HF requires further elucidation.

Purpose of the Study:

  • To investigate the association between hematocrit levels and the risk of developing symptomatic heart failure (HF).
  • To examine the relationship between hematocrit and adverse cardiovascular outcomes in patients with LV systolic dysfunction.

Main Methods:

  • Analysis of data from 2,821 patients enrolled in the Studies of Left Ventricular Dysfunction Prevention trial.
  • Stratification of patients into quartiles based on hematocrit levels.
  • Utilizing survival analysis to determine hazard ratios (HR) and 95% confidence intervals (CI) for HF development and related events.

Main Results:

  • Patients in the lowest hematocrit quartile (hematocrit <= 40%) demonstrated a significantly increased risk of developing HF symptoms (HR 1.79, 95% CI 1.37 to 2.34).
  • Lower hematocrit was also associated with a higher risk of first HF hospitalization (HR 2.35, 95% CI 1.52 to 3.62).
  • The risk of death or HF symptom development was elevated in the lowest hematocrit quartile (HR 1.60, 95% CI 1.28 to 1.99) compared to the highest quartile (hematocrit > 46%).

Conclusions:

  • Hematocrit levels may serve as a prognostic marker for HF progression in patients with asymptomatic LV systolic dysfunction.
  • Lower hematocrit is associated with an increased risk of adverse outcomes, including symptomatic HF and hospitalization.
  • Further research is warranted to explore the underlying mechanisms and clinical implications of this association.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...